Follow me on TwitterTweets by @CentreSysmed
Author Archives: Helena Bonner
congratulations to Valintino, Amaya, Ian, Franziska and Micha for obtaining the 2018 departmental awards presented by the head of department Prof. Jochen Prehn. The awards aim to recognize individuals for their hard work during the year.
The Royal Academy of Medicine in Ireland in association with the Irish Journal of Medical Science held a very successful event on Wednesday 29th November 2017 which took place in the Royal College of Physicians. Dr. Ian Miller receiving RAMI Research Award in Oncology … Continue reading
The Young NSI 2018 Conference took place in UCD on Thursday 25th October. Irene was invited to speak at the conference. Her talk was entitled ‘A combined single-cell imaging and population assay approach to determine and therapeutically target the control … Continue reading
CSM Director of Imaging Dr. Heiko Duessmann gives a a talk at the MIAP workshop in the Live Imaging Cell (LIC) facility at the Albert-Ludwigs-University Freiburg
17th October The Life Imaging Center (LIC) is a central core facility of the Albert-Ludwigs-University Freiburg open to members of all Faculties. Currently 250 active users from 6 Faculties (Biology; Medicine; Chemistry and Pharmacy; Mathematics and Physics; Environment and Natural Resources; and … Continue reading
Dr Connolly was invited by Dr Ted Burke from the DIT School of Electrical Engineering to chat with the students about her career path to first year engineering students.
CSM researchers and collaborators discover that high chromosomal instability may predict which patients will benefit most from colorectal cancer drug
Research aims to make sure that patients only receive drugs that will work specifically for their own disease Wednesday, 10 October 2018: Researchers at RCSI/CSM, along with international collaborators within the ANGIOPREDICT research consortium, have discovered that chromosomal instability (where … Continue reading
Scientists discover predictive biomarker for key colorectal cancer drug Friday, 01 June 2018: The ANGIOPREDICT research consortium have discovered a potential biomarker that can predict which patients will receive most benefit from a key drug used to treat colorectal cancer (Avastin). … Continue reading
Monday 30th April 34 students and 2 professors from Radboud University Nijmegen (the Netherlands) visited RCSI and the CSM labs. They were welcomed by Prof. Prehn and Dr Helena Bonner and spent the day listening to presentations on the research … Continue reading
Our miRNAmeConverter package (https://bit.ly/2fFe5BA) now supports miRBase 22! (doi:10.1093/bioinformatics/btw660)